Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE2
Sponsor: First Affiliated Hospital of Zhejiang University
Condition: Acute Lymphoblastic Leukemia, B Cell ALL
NCT06777264
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal | long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: rare_population_signal | complex_intervention_signal
Stopped reason
Context when available
No stop reason available in the current public record.